Zobrazeno 1 - 10
of 46
pro vyhledávání: '"David M Swoboda"'
Autor:
Syed Muhammad Waqar Haider, Mehwish Zehra, Nikesh N Shah, Eduardo M Sotomayor, David M Swoboda
Publikováno v:
Leukemia Research Reports, Vol 21, Iss , Pp 100461- (2024)
A 67-year-old female came to Tampa General Hospital with Philadelphia chromosome-positive (Ph+) acute myeloid leukemia (AML) featuring an intriguing combination of mutations, including NPM1 and IDH2 mutations. Novel combination therapy with azacitidi
Externí odkaz:
https://doaj.org/article/90e7c5ede15d442d8b469d7d5866f487
Autor:
Neeraj Y. Saini, David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil D. Patel, Kartik Devashish, Kaberi Das, Mark R. Tanner, Paolo Strati, Ranjit Nair, Luis Fayad, Sairah Ahmed, Hun Ju Lee, Swaminathan P. Iyer, Raphael Steiner, Nitin Jain, Loretta Nastoupil, Sanam Loghavi, Guilin Tang, Roland L. Bassett, Preetesh Jain, Michael Wang, Jason R. Westin, Michael R. Green, David A. Sallman, Eric Padron, Marco L. Davila, Frederick L. Locke, Richard E. Champlin, Guillermo Garcia-Manero, Elizabeth J. Shpall, Partow Kebriaei, Christopher R. Flowers, Michael D. Jain, Feng Wang, Andrew P. Futreal, Nancy Gillis, Sattva S. Neelapu, Koichi Takahashi
Publikováno v:
Blood Cancer Discov
To explore the role of clonal hematopoiesis (CH) in chimeric antigen receptor (CAR) T-cell therapy outcomes, we performed targeted deep sequencing on buffy coats collected during the 21 days before lymphodepleting chemotherapy from 114 large B-cell l
Publikováno v:
Leukemia Research Reports, Vol 12, Iss , Pp - (2019)
Myeloid Sarcoma (MS) is diagnosed by an extramedullary proliferation of immature granulocytic cells. Its association with chronic myeloid leukemia (CML) is rare. CML is characterized by BCR-ABL1 gene rearrangement and therapies with tyrosine kinase i
Externí odkaz:
https://doaj.org/article/345994ea2ad04b1e84d026ee1bfc015c
Autor:
Koichi Takahashi, Sattva S. Neelapu, Nancy Gillis, Andrew P. Futreal, Feng Wang, Michael D. Jain, Christopher R. Flowers, Partow Kebriaei, Elizabeth J. Shpall, Guillermo Garcia-Manero, Richard E. Champlin, Frederick L. Locke, Marco L. Davila, Eric Padron, David A. Sallman, Michael R. Green, Jason R. Westin, Michael Wang, Preetesh Jain, Roland L. Bassett, Guilin Tang, Sanam Loghavi, Loretta Nastoupil, Nitin Jain, Raphael Steiner, Swaminathan P. Iyer, Hun Ju Lee, Sairah Ahmed, Luis Fayad, Ranjit Nair, Paolo Strati, Mark R. Tanner, Kaberi Das, Kartik Devashish, Romil D. Patel, Junsheng Ma, Uri Greenbaum, David M. Swoboda, Neeraj Y. Saini
To explore the role of clonal hematopoiesis (CH) in chimeric antigen receptor (CAR) T-cell therapy outcomes, we performed targeted deep sequencing on buffy coats collected during the 21 days before lymphodepleting chemotherapy from 114 large B-cell l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f676a1acde029f8ef1feb25ae940423
https://doi.org/10.1158/2643-3230.c.6550812
https://doi.org/10.1158/2643-3230.c.6550812
Autor:
Koichi Takahashi, Sattva S. Neelapu, Nancy Gillis, Andrew P. Futreal, Feng Wang, Michael D. Jain, Christopher R. Flowers, Partow Kebriaei, Elizabeth J. Shpall, Guillermo Garcia-Manero, Richard E. Champlin, Frederick L. Locke, Marco L. Davila, Eric Padron, David A. Sallman, Michael R. Green, Jason R. Westin, Michael Wang, Preetesh Jain, Roland L. Bassett, Guilin Tang, Sanam Loghavi, Loretta Nastoupil, Nitin Jain, Raphael Steiner, Swaminathan P. Iyer, Hun Ju Lee, Sairah Ahmed, Luis Fayad, Ranjit Nair, Paolo Strati, Mark R. Tanner, Kaberi Das, Kartik Devashish, Romil D. Patel, Junsheng Ma, Uri Greenbaum, David M. Swoboda, Neeraj Y. Saini
Supplementary Figure from Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1746c7e5555d42f3327bc2ed61500b38
https://doi.org/10.1158/2643-3230.22544967.v1
https://doi.org/10.1158/2643-3230.22544967.v1
Autor:
Andrew T. Kuykendall, David A. Sallman, Rami S. Komrokji, Najla Al Ali, David M Swoboda, Eric Padron, Onyee Chan, Virginia O. Volpe
Publikováno v:
Blood. 138:989-992
Komrokji et al examined the proposed international working group proposal to designate SF3B1-mutant myelodysplastic syndrome (MDS) as a unique disease entity, using a single-institution validation cohort of 1779 MDS patients, of whom 320 harbored SF3
Autor:
Mrinal M. Patnaik, Kaaren K. Reichard, Christy Finke, Rhett P. Ketterling, Chetasi Talati, Terra L. Lasho, David M Swoboda, Abhishek A. Mangaonkar, Eric Padron
Publikováno v:
Leukemia. 35:3329-3333
Autor:
Somedeb Ball, Akriti G. Jain, Luis E. Aguirre, Najla Al Ali, Yumeng Zhang, Onyee Chan, Andrew T. Kuykendall, Kendra L. Sweet, Jeffrey E. Lancet, David M. Swoboda, Eric Padron, Rami S. Komrokji, David A. Sallman
Publikováno v:
American Journal of Hematology. 97
Publikováno v:
Current Opinion in Hematology. 27:58-65
Purpose of review Currently, there is a rapid expansion of novel, efficacious therapies for the treatment of patients with myelodysplastic syndromes (MDS) at a rate never seen to date. In this review, we will outline new treatment strategies in MDS f
Autor:
Neeraj Y. Saini, David M. Swoboda, Uri Greenbaum, Jungsheng Ma, Romil Patel, Kartik Devashish, Kaberi Das, Mark R. Tanner, Paolo Strati, Ranjit Nair, Luis E. Fayad, Sairah Ahmed, Hun Ju Lee, Swaminathan Iyer, Raphael Steiner, Nitin Jain, Loretta Nastoupil, Sanam Loghavi, Guilin Tang, Preetesh Jain, Michael Wang, Jason Westin, Michael R. Green, David Sallman, Eric Padron, Marco Davila, Frederick L. Locke, Richard Champlin, Elizabeth Shpall, Partow Kebriaei, Christopher R. Flowers, Michael Jain, Feng Wang, Andrew Futreal, Nancy Gillis, Sattva S. Neelapu, Koichi Takahashi
To explore the role of clonal hematopoiesis (CH) on chimeric antigen receptor (CAR) T-cell therapy outcomes, we performed targeted deep-sequencing on 114 large B-cell lymphoma patients treated with anti-CD19 CAR T-cells. We detected CH in 42 (36.8%)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cde9269890494bf3bc2d3b2e2bfe255a
https://doi.org/10.1101/2021.09.28.461858
https://doi.org/10.1101/2021.09.28.461858